Sangamo Therapeutics (SGMO)

$0.56 +0.02 (4.56%)
Market Cap 125.23M
Revenue (ttm) 57.80M
Net Income (ttm) -97.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -169.45%
Debt to Equity Ratio 0.00
Volume 4,227,400
Avg Vol 5,454,682
Day's Range N/A - N/A
Shares Out 233.17M
Stochastic %K 38%
Beta 1.23
Analysts Strong Sell
Price Target $4.10

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
Swamp_Yankee
Swamp_Yankee Aug. 1 at 11:48 PM
$SGMO "it's much easier putting this on an arm. I only agreed to put it on Sandy's ass because he gave $10,000.00."
0 · Reply
Crash_Bash
Crash_Bash Aug. 1 at 11:00 PM
$SGMO last year in aug 6th Q2 they annouced capsid deal in the PR and ER was after market close. Lets hope we get some news this time and a material one too. All eyes on this call. They have cash until late Q3 meaning end of Aug or early Sept. Really hoping for some postives here, its so hard to dilute and raise at this level.
0 · Reply
EddieH2020
EddieH2020 Aug. 1 at 10:58 PM
$SGMO If this tanks to .40 I’m buying 50k more shares at least
2 · Reply
DingleberryDave
DingleberryDave Aug. 1 at 10:51 PM
$SGMO Some Very Interesting Posts/Opinion from other forum (SEE COMMENTS)
3 · Reply
Crash_Bash
Crash_Bash Aug. 1 at 10:44 PM
$SGMO man they would not fill me at .56!!!!!
0 · Reply
DingleberryDave
DingleberryDave Aug. 1 at 10:36 PM
$SGMO https://ppubs.uspto.gov/api/patents/html/20250243512?source=US-PGPUB&requestToken=eyJzdWIiOiJjZGUzMGExZS0zNDY3LTQ4ZDUtOGI5YS1kNjQxNjJmZGNjNzMiLCJ2ZXIiOiI4OGU3YzVlNC1lMmUyLTRjNzUtOTBhMi1kYzdjOTIyYjk1MjgiLCJleHAiOjB9
1 · Reply
SilentSniper
SilentSniper Aug. 1 at 8:37 PM
$SGMO only green in my portfolio today
2 · Reply
TwoThirdsProbablyDown
TwoThirdsProbablyDown Aug. 1 at 8:34 PM
Not going to think about $SGMO this weekend…NOT going to think about $SGMO THIS WEEKEND!!!
2 · Reply
Xfaster
Xfaster Aug. 1 at 8:02 PM
$SGMO Add More
0 · Reply
hamm461
hamm461 Aug. 1 at 8:00 PM
$SGMO
0 · Reply
Latest News on SGMO
Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Jul 31, 2025, 4:05 PM EDT - 1 day ago

Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

Jun 24, 2025, 8:05 AM EDT - 5 weeks ago

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease

Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:06 PM EDT - 2 months ago

Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results

May 12, 2025, 6:26 PM EDT - 2 months ago

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering

May 12, 2025, 6:23 PM EDT - 2 months ago

Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

May 12, 2025, 4:00 PM EDT - 2 months ago

Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

May 6, 2025, 4:35 PM EDT - 3 months ago

Sangamo Therapeutics Announces First Quarter 2025 Earnings Call

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

May 6, 2025, 8:30 AM EDT - 3 months ago

Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Apr 28, 2025, 4:31 PM EDT - 3 months ago

Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal

Apr 4, 2025, 2:57 PM EDT - 4 months ago

Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal

Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System

Apr 3, 2025, 4:01 PM EDT - 4 months ago

Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System

Sangamo Therapeutics, Inc. (SGMO) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 6:29 PM EDT - 4 months ago

Sangamo Therapeutics, Inc. (SGMO) Q4 2024 Earnings Call Transcript

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Mar 17, 2025, 4:01 PM EDT - 4 months ago

Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

Mar 6, 2025, 4:05 PM EST - 5 months ago

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

Feb 6, 2025, 8:05 AM EST - 6 months ago

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sangamo Therapeutics, Inc. (SGMO) And Encourages Shareholders to Reach Out

Jan 15, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sangamo Therapeutics, Inc. (SGMO) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Shareholders to Learn More About the Investigation

Jan 14, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Shareholders to Learn More About the Investigation

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jan 13, 2025, 10:00 AM EST - 7 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Shareholders to Inquire about Securities Investigation

Jan 12, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Shareholders to Inquire about Securities Investigation

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 10, 2025, 10:00 AM EST - 7 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Investors to Connect

Jan 9, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Stockholders to Inquire about Securities Investigation

Jan 8, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Investors to Learn More About the Investigation

Jan 7, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Stockholders to Connect

Jan 6, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sangamo Therapeutics, Inc. (SGMO) And Encourages Stockholders to Connect

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 7 months ago

Sangamo Therapeutics, Inc. (SGMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Stockholders to Learn More About the Investigation

Jan 3, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sangamo Therapeutics, Inc. (SGMO) and Encourages Stockholders to Learn More About the Investigation

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Jan 2, 2025, 6:00 PM EST - 7 months ago

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Sangamo Therapeutics, Inc. (SGMO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Jan 2, 2025, 4:00 PM EST - 7 months ago

Sangamo Therapeutics, Inc. (SGMO) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Jan 2, 2025, 3:05 PM EST - 7 months ago

Securities Fraud Investigation Into Sangamo Therapeutics, Inc. (SGMO) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Investors to Inquire about Securities Investigation

Jan 2, 2025, 10:15 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Sangamo Therapeutics, Inc. (SGMO) Investors to Inquire about Securities Investigation

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

Dec 31, 2024, 12:01 PM EST - 7 months ago

Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet

Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact

Dec 31, 2024, 11:22 AM EST - 7 months ago

Sangamo Therapeutics' stock falls the most in 16 years after Pfizer ends Hemophilia pact

PFE

Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact

Dec 31, 2024, 11:20 AM EST - 7 months ago

Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

Dec 31, 2024, 9:14 AM EST - 7 months ago

Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact

PFE

Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Dec 31, 2024, 8:47 AM EST - 7 months ago

Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Swamp_Yankee
Swamp_Yankee Aug. 1 at 11:48 PM
$SGMO "it's much easier putting this on an arm. I only agreed to put it on Sandy's ass because he gave $10,000.00."
0 · Reply
Crash_Bash
Crash_Bash Aug. 1 at 11:00 PM
$SGMO last year in aug 6th Q2 they annouced capsid deal in the PR and ER was after market close. Lets hope we get some news this time and a material one too. All eyes on this call. They have cash until late Q3 meaning end of Aug or early Sept. Really hoping for some postives here, its so hard to dilute and raise at this level.
0 · Reply
EddieH2020
EddieH2020 Aug. 1 at 10:58 PM
$SGMO If this tanks to .40 I’m buying 50k more shares at least
2 · Reply
DingleberryDave
DingleberryDave Aug. 1 at 10:51 PM
$SGMO Some Very Interesting Posts/Opinion from other forum (SEE COMMENTS)
3 · Reply
Crash_Bash
Crash_Bash Aug. 1 at 10:44 PM
$SGMO man they would not fill me at .56!!!!!
0 · Reply
DingleberryDave
DingleberryDave Aug. 1 at 10:36 PM
$SGMO https://ppubs.uspto.gov/api/patents/html/20250243512?source=US-PGPUB&requestToken=eyJzdWIiOiJjZGUzMGExZS0zNDY3LTQ4ZDUtOGI5YS1kNjQxNjJmZGNjNzMiLCJ2ZXIiOiI4OGU3YzVlNC1lMmUyLTRjNzUtOTBhMi1kYzdjOTIyYjk1MjgiLCJleHAiOjB9
1 · Reply
SilentSniper
SilentSniper Aug. 1 at 8:37 PM
$SGMO only green in my portfolio today
2 · Reply
TwoThirdsProbablyDown
TwoThirdsProbablyDown Aug. 1 at 8:34 PM
Not going to think about $SGMO this weekend…NOT going to think about $SGMO THIS WEEKEND!!!
2 · Reply
Xfaster
Xfaster Aug. 1 at 8:02 PM
$SGMO Add More
0 · Reply
hamm461
hamm461 Aug. 1 at 8:00 PM
$SGMO
0 · Reply
TheFrenchBuzz
TheFrenchBuzz Aug. 1 at 7:59 PM
$SGMO What a good surprise. I thought yesterday the share price would drop to $0.49.
0 · Reply
JimiJoJeeter
JimiJoJeeter Aug. 1 at 7:57 PM
$SGMO Another one 500+k....
1 · Reply
SusQSmallMouth
SusQSmallMouth Aug. 1 at 7:38 PM
$SGMO wouldn't it be nice if Sandy gave us one happy Friday in our lifetime? 🤞
2 · Reply
JasonRKT
JasonRKT Aug. 1 at 7:31 PM
$SGMO dilution next week. Get ready. ☠️
2 · Reply
JimiJoJeeter
JimiJoJeeter Aug. 1 at 7:28 PM
$SGMO Nice pivot... 309.7k shares
0 · Reply
Jeffkad
Jeffkad Aug. 1 at 7:17 PM
$SGMO hahaha, an island of green in a sea of red. The world truly makes no sense lol
0 · Reply
Xfaster
Xfaster Aug. 1 at 7:15 PM
$SGMO
0 · Reply
Usually_Im_Right
Usually_Im_Right Aug. 1 at 7:12 PM
$SGMO next $EQ 🚀
0 · Reply
WoldanStanford
WoldanStanford Aug. 1 at 6:05 PM
$SGMO where did sgmo get money on 25$ per share and now its on 0.50$ ??
1 · Reply
Crash_Bash
Crash_Bash Aug. 1 at 5:23 PM
$SGMO $SRPT my two largest holdings are reporting earnings back to back next week... what could go wrong lol
2 · Reply
Idvst8
Idvst8 Aug. 1 at 5:15 PM
$SGMO - Going to be an interesting 1st Week in August with ole Sangamo. Time to Deal
0 · Reply
WoldanStanford
WoldanStanford Aug. 1 at 5:01 PM
$SGMO
0 · Reply